Masafumi Sakashita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Masafumi Sakashita has a total of 136 co-authors. Here are the top co-authors by number of shared publications:
Shigeharu Fujieda
Department of Otorhinolaryngology and Head & Neck Surgery, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan
5 shared publications- Shigeharu Fujieda
Fukui Daigaku Igakubu Jibi Inkoka Tokeibu Geka
4 shared publications - Tetsuji Takabayashi
Division of Otorhinolaryngology—Head and Neck Surgery, Department of Sensory and Locomotor Medicine, Faculty of Medical Sciences University of Fukui Fukui Japan
4 shared publications Kanako Yoshida
Division of Otorhinolaryngology Head and Neck Surgery, Department of Sensory and Locomotor Medicine, University of Fukui, Fukui, Japan
3 shared publications- Kanako Yoshida
Fukui Daigaku Igakubu Jibi Inkoka Tokeibu Geka
3 shared publications - Kazuhiro Ogi
Fukui Daigaku Igakubu Jibi Inkoka Tokeibu Geka
3 shared publications
Latest Publications
- Open Access
- 14 August 2026
- Published by Elsevier in Allergology International
Nasal Corynebacterium depletion is associated with polysensitization to inhalant allergens in adults
- 14 August 2026
- Published by Elsevier in Allergology International
Open AccessNasal Corynebacterium depletion is associated with polysensitization to inhalant allergens in adults
- 21 June 2025
- Published by Elsevier in Auris Nasus Larynx
- Vol. 52 (4) , 426-441
Practical guideline for the management of allergic rhinitis in Japan 2024
- 21 June 2025
- Published by Elsevier in Auris Nasus Larynx
- Vol. 52 (4) , 426-441
Practical guideline for the management of allergic rhinitis in Japan 2024
- 10 October 2024
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 72 (11-12) , 683-692
High M2/M1 Macrophage Ratio Observed in Nasal Polyps Formed in Allergic Fungal Rhinosinusitis
Allergic fungal rhinosinusitis (AFRS) shares similarities with eosinophilic chronic rhinosinusitis (ECRS), both characterized by intractable nasal polyps. The key distinction lies in the presence of fungal infection within the nasal cavity. While ECRS nasal polyps are known for significant infiltration of M2 macrophages and eosinophils, as well as an increase in high endothelial venule (HEV)-like vessels, these features are less commonly reported in AFRS. This study compared clinicopathological findings between AFRS ( n=10), ECRS ( n=12), and non-ECRS ( n=10) patients’ nasal polyps using immunohistochemical analysis for CD163 and CD68 to assess the M2/M1 macrophage ratio, and peripheral lymph node addressin (PNAd) and CD34 to evaluate the proportion of HEV-like vessels. AFRS showed a significantly higher number of CD163-positive M2 macrophages and an increased M2/M1 ratio compared with ECRS. However, the percentage of HEV-like vessels and the number of eosinophils infiltrating the nasal polyps were similar in both AFRS and ECRS. The observed increase in M2 macrophages in AFRS nasal polyps is presumed to be induced by fungal infection in the nasal cavity, in comparison with ECRS. These results highlight the distinctive immunological profiles of AFRS and ECRS, emphasizing the role of macrophage polarization in their pathogenesis.
- 10 October 2024
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 72 (11-12) , 683-692
High M2/M1 Macrophage Ratio Observed in Nasal Polyps Formed in Allergic Fungal Rhinosinusitis
Allergic fungal rhinosinusitis (AFRS) shares similarities with eosinophilic chronic rhinosinusitis (ECRS), both characterized by intractable nasal polyps. The key distinction lies in the presence of fungal infection within the nasal cavity. While ECRS nasal polyps are known for significant infiltration of M2 macrophages and eosinophils, as well as an increase in high endothelial venule (HEV)-like vessels, these features are less commonly reported in AFRS. This study compared clinicopathological findings between AFRS ( n=10), ECRS ( n=12), and non-ECRS ( n=10) patients’ nasal polyps using immunohistochemical analysis for CD163 and CD68 to assess the M2/M1 macrophage ratio, and peripheral lymph node addressin (PNAd) and CD34 to evaluate the proportion of HEV-like vessels. AFRS showed a significantly higher number of CD163-positive M2 macrophages and an increased M2/M1 ratio compared with ECRS. However, the percentage of HEV-like vessels and the number of eosinophils infiltrating the nasal polyps were similar in both AFRS and ECRS. The observed increase in M2 macrophages in AFRS nasal polyps is presumed to be induced by fungal infection in the nasal cavity, in comparison with ECRS. These results highlight the distinctive immunological profiles of AFRS and ECRS, emphasizing the role of macrophage polarization in their pathogenesis.
- 26 August 2023
- Published by Elsevier in Auris Nasus Larynx
- Vol. 51 (2) , 391-400
Translational research in head and neck cancer: Molecular and immunological updates
- 26 August 2023
- Published by Elsevier in Auris Nasus Larynx
- Vol. 51 (2) , 391-400
Translational research in head and neck cancer: Molecular and immunological updates
- Top Cited PapersOpen Access
- 11 August 2023
- Published by Elsevier in Auris Nasus Larynx
- Vol. 51 (1) , 51-60
The current findings in eosinophilic chronic rhinosinusitis
- 11 August 2023
- Published by Elsevier in Auris Nasus Larynx
- Vol. 51 (1) , 51-60
Top Cited PapersOpen AccessThe current findings in eosinophilic chronic rhinosinusitis
- 18 June 2022
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 150 (5) , 1114-1124.e3
Retinoic acid promotes fibrinolysis and may regulate polyp formation
- 18 June 2022
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 150 (5) , 1114-1124.e3
Retinoic acid promotes fibrinolysis and may regulate polyp formation
- Open Access
- 21 March 2022
- Published by Elsevier in Allergology International
- Vol. 71 (3) , 354-361
Evaluation of adrenaline auto-injector prescription profiles: A population-based, retrospective cohort study within the National Insurance Claims Database of Japan
- 21 March 2022
- Published by Elsevier in Allergology International
- Vol. 71 (3) , 354-361
Open AccessEvaluation of adrenaline auto-injector prescription profiles: A population-based, retrospective cohort study within the National Insurance Claims Database of Japan
- 15 June 2021
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 206 (12) , 2791-2802
Involvement of Activation of Mast Cells via IgE Signaling and Epithelial Cell–Derived Cytokines in the Pathogenesis of Pollen Food Allergy Syndrome in a Murine Model
Murine models to elucidate the pathogenesis of pollen food allergy syndrome (PFAS), characterized by oral hypersensitivity symptoms induced by specific foods in patients previously sensitized with a pollen, are lacking. The study aimed to examine PFAS pathogenesis in a novel murine model. Birch pollen–immunized mice were orally administered apple extract, and oral symptoms were evaluated based on oral rubbing frequency following the challenge. The birch pollen–immunized mice orally challenged with apple extract exhibited PFAS-like symptoms, including oral rubbing and positive reaction of swelling by the prick test. The apple extract administered with a protease inhibitor reduced the oral rubbing frequency, which was also significantly reduced in the immunized Fcer1a−/− and mast cell–deficient mice compared with the immunized control mice. The oral rubbing frequency, serum IgE levels, and Th2-cytokine production by the cervical lymph node cells were significantly reduced in the immunized Il-33−/− and thymic stromal lymphopoietin receptor–deficient (Crlf2−/−) mice as compared with the immunized wild-type mice. IL-33 and thymic stromal lymphopoietin involve the pathogenesis of PFAS. The apple-extract stimulation did not lead to increased Th2-cytokine production in the oral mucosa or number of group 2 innate lymphoid cells or eosinophils. PFAS involves an early-phase response by mast cell degranulation via IgE signaling after the cross-reactivity of Bet v 1–specific IgE and the food allergen, and exacerbation of allergic symptom via proteases in food; PFAS does not involve a late phase with local Th2/eosinophilic inflammation in the oral mucosa. This novel murine model might be used for elucidating the pathogenesis and assessing new therapeutic strategies for PFAS. Key Points The activation of mast cells via IgE signaling induces the early phase of PFAS. IL-33 and TSLP involve the pathogenesis of PFAS. Our murine model might provide a useful therapeutic platform for PFAS.
- 15 June 2021
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 206 (12) , 2791-2802
Involvement of Activation of Mast Cells via IgE Signaling and Epithelial Cell–Derived Cytokines in the Pathogenesis of Pollen Food Allergy Syndrome in a Murine Model
Murine models to elucidate the pathogenesis of pollen food allergy syndrome (PFAS), characterized by oral hypersensitivity symptoms induced by specific foods in patients previously sensitized with a pollen, are lacking. The study aimed to examine PFAS pathogenesis in a novel murine model. Birch pollen–immunized mice were orally administered apple extract, and oral symptoms were evaluated based on oral rubbing frequency following the challenge. The birch pollen–immunized mice orally challenged with apple extract exhibited PFAS-like symptoms, including oral rubbing and positive reaction of swelling by the prick test. The apple extract administered with a protease inhibitor reduced the oral rubbing frequency, which was also significantly reduced in the immunized Fcer1a−/− and mast cell–deficient mice compared with the immunized control mice. The oral rubbing frequency, serum IgE levels, and Th2-cytokine production by the cervical lymph node cells were significantly reduced in the immunized Il-33−/− and thymic stromal lymphopoietin receptor–deficient (Crlf2−/−) mice as compared with the immunized wild-type mice. IL-33 and thymic stromal lymphopoietin involve the pathogenesis of PFAS. The apple-extract stimulation did not lead to increased Th2-cytokine production in the oral mucosa or number of group 2 innate lymphoid cells or eosinophils. PFAS involves an early-phase response by mast cell degranulation via IgE signaling after the cross-reactivity of Bet v 1–specific IgE and the food allergen, and exacerbation of allergic symptom via proteases in food; PFAS does not involve a late phase with local Th2/eosinophilic inflammation in the oral mucosa. This novel murine model might be used for elucidating the pathogenesis and assessing new therapeutic strategies for PFAS. Key Points The activation of mast cells via IgE signaling induces the early phase of PFAS. IL-33 and TSLP involve the pathogenesis of PFAS. Our murine model might provide a useful therapeutic platform for PFAS.
- Open Access
- 1 January 2021
- Published by Elsevier in Allergology International
- Vol. 70 (1) , 89-95
Comparison of sensitization and prevalence of Japanese cedar pollen and mite-induced perennial allergic rhinitis between 2006 and 2016 in hospital workers in Japan
- 1 January 2021
- Published by Elsevier in Allergology International
- Vol. 70 (1) , 89-95
Open AccessComparison of sensitization and prevalence of Japanese cedar pollen and mite-induced perennial allergic rhinitis between 2006 and 2016 in hospital workers in Japan